The study mines Thomson Reuter’s own “Web of Science,” a scientific citation indexing service, to highlight the most influential researchers in four categories: chemistry, physics, physiology or medicine, and economics.
Here are three groups of laureates with medical-related research.
1. For explaining how the protein CD28 and protein receptor CTLA-4 regulate T cell activation and therefore control immune response:
- James Allison, PhD, professor and chair, department of immunology, MD Anderson Cancer Center (Houston)
- Jeffrey Bluestone, PhD, professor of metabolism and endocrinology, UCSF Medical School (San Francisco)
- Craig Thompson, MD, president and CEO, Memorial Sloan Kettering Cancer Center (New York)
2. For advancing immunotherapy by elucidating the protein PD-1 and its pathway:
- Gordon Freeman, PhD, professor, department of medical oncology, Dana-Farber Cancer Institute (Boston), professor of medicine, Harvard Medical School (Boston)
- Tasuku Honjo, MD, PhD, visiting professor, Kyoto (Japan) University
- Arlene Sharpe, MD, PhD, professor of comparative pathology, department of microbiology and immunobiology, Harvard Medical School (Boston), member of the department of pathology, Brigham and Women’s Hospital (Boston)
3. For discovering the enhanced permeability and retention effect of macromolecular drugs, advancing cancer therapeutics:
- Hiroshi Maeda, MD, PhD, professor, Institute of Drug Delivery Science, Sojo University (Kumamoto, Japan), professor emeritus, Kumamoto (Japan) University School of Medicine
- Yasuhiro Matsumura, MD, director, Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center (Tokyo)
Find a listing of the rest of the laureates here.
More articles on leadership and management:
The effects of CMS’ star ratings: 5 things hospital leaders should know
Former Mayo CEO Gene Mayberry dies at 87
With potential exodus at federal agency, billions of dollars in research grants in jeopardy
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
